Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CANINE PARAINFLUENZA; LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN; CANINE ADENO VIRUS TYPE 2; CANINE CORONAVIRUS VACCINE - ANTIGEN; CANINE DISTEMPER VIRUS; CANINE PARVO VIRUS
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
canine distemper virus+canine adenovirus+vaccine - canine parainfluen + others
MISC. VACCINES OR ANTI SERA
CANINE PARAINFLUENZA VACCINE Active 0.0 Undefined; LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN VACCINE-ANTIGEN Active 0.0 Undefined; CANINE ADENO VIRUS TYPE 2 VACCINE-VIRAL Active 0.0 Undefined; CANINE CORONAVIRUS VACCINE - ANTIGEN VACCINE-VIRAL Active 0.0 Undefined; CANINE DISTEMPER VIRUS VACCINE-VIRAL Active 0.0 Undefined; CANINE PARVO VIRUS VACCINE-VIRAL Active 0.0 Undefined
25 x 1 dose Protech C4 and 25 x 1 dose C2i
VM - Veterinary Medicine
DOG - OVER 6 WEEKS OLD
IMMUNOTHERAPY
CANINE ADENOVIRUS - TYPE 1 | CANINE ADENOVIRUS - TYPE 2 | CANINE CORONAVIRUS | CANINE DISTEMPER | CANINE PARAINFLUENZA | CANINE PARVOVIRUS | LEPTOSPIRA ICTEROHAEMORRHAGIAE | PARVOVIRUS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OVER 6 WEEKS OLD: [CANINE ADENOVIRUS - TYPE 1, CANINE ADENOVIRUS - TYPE 2, CANINE CORONAVIRUS, CANINE DISTEMPER, CANINE PARAINFLUENZA, CANINE PARVOVIRUS, LEPTOSPIRA ICTEROHAEMORRHAGIAE]; Live vaccine for the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by canine distemper virus, canine adenovirus types 1&2, canine parainfluenza virus, canine parvovirus & L. interrogans sv. Copenhageni & aid in .See DIRECTIONS FOR USE, PRECAUTIONS and SIDE EFFECTS on label.
Registered
2023-07-01
BOEHRINGER INGELHEIM PTY LIMITED, VETMEDICA DIVISION PROTECH C4 + 2I 51489/101279 COMPANY NAME: PRODUCT NAME: APVMA APPROVAL NO: LABEL NAME: PROTECH C4 + 2I SIGNAL HEADINGS: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: Attenuated canine distemper virus (10^2.9 TCID50) Attenuated canine adenovirus type 2 (10^3.62 TCID50) Attenuated canine parvovirus (CPV-2b strain 10^5.5 TCID50) Attenuated canine parainfluenza virus type 2 (10^4.55 TCID50) Inactivated canine coronavirus (RP ≥ 1.62) Inactivated bacterins of Leptospira interrogans serovar Copenhageni (RP ≥ 1.0) CLAIMS: Live vaccine for the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2, canine parainfluenza virus, canine parvovirus and Leptospira interrogans serovar Copenhageni and aid in protection against disease caused by canine coronavirus. This vaccine prevents viral shedding caused by canine parvovirus infection. Early protection of puppies with final vaccination at 10 weeks. NET CONTENTS: 25 x 1 dose Protech C4 25 x 1 dose Protech C2i DIRECTIONS FOR USE: A new sterile syringe and needle should always be used to administer this vaccine. Reconstitute the freeze-dried Protech® C4 vaccine with sterile water for injection (1 mL) or Protech® C2i vaccine. Inject subcutaneously within 20 minutes of reconstitution. Do not use chemicals or disinfectants to sterilise the skin, needles or syringes. RESTRAINTS: CONTRAINDICATIONS: PRECAUTIONS: Vaccinate only healthy dogs with normal temperatures. Dogs under treatment with immunosuppressive drugs should not be vaccinated. RLP APPROVED The use of these vaccines in pregnant bitches is not recommended. SIDE EFFECTS: Some animals may show transient post-vaccination pain, malaise and depression. Allergic reactions such as anaphylaxis occur rarely and may require parenteral treatment with an antihistamine, a corticosteroid or adrenalin as appropr Soma hati kamili
CS: 1.7.2 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ08H August 2011 ISSUED by BOEHRING Issue Date : PROTECH® C4 +2I Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER PROTECH® C4 +2I PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL For the immunisation of healthy dogs against diseases caused by Canine Distemper, Canine Adenovirus types 1 and 2, Canine Parainfluenza, Canine Parvovirus, Canine Coronavirus and Leptospira interrogans serovar Copenhageni. RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Hazard classification according to the criteria of NOHSC. Dangerous goods classification according to the Australia Dangerous Goods Code. HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS Product contains Canine distemper virus, Canine adenovirus, Canine parvovirus, Canine parainfluenza virus, Canine coronavirus and Leptospira interrogans serovar Copenhageni. INFORMATION ON COMPOSITION NAME CAS PROPORTION INGREDIENTS Ingredients determined not to be hazardous - Balance Live virus vaccine - 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mouth thoroughly with water. If symptoms develop seek medical attention. INGESTION Wash affected area thoroughly with soap and water. If symptoms develop seek medical attention. Self-Injection: Accidental self injection may lead to an inflammatory response and medical advice should be sought on the management of deep injections, particularly those near a joint or associated with bruising. If possible the application of gentle squeezing pressure with absorbent material Soma hati kamili
TOP (B) Exp.: PROTECH® C4+2I 176501-00 Live vaccine for the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2, canine parainfluenza virus, canine parvovirus and Leptospira interrogans serovar Copenhageni and aid in protection against disease caused by canine coronavirus. Early protection of puppies with final vaccination at 10 weeks. READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DOSE: Contents of one vial of PROTECH C4 to be reconstituted with one vial of PROTECH C2I injected subcutaneously. Store between 2-8°C. Do not freeze. Protect from light. abcd PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY PROTECH® C4+2I ACTIVE CONSTITUENTS: attenuated canine distemper virus (10 2.9 TCID 50 ), canine adenovirus type 2 (10 3.62 TCID 50 ), canine parvovirus (CPV-2b strain, 10 5.5 TCID 50 ) and canine parainfluenza Type 2 (10 4.55 TCID 50 ), inactivated canine coronavirus (RP≥ 1.62) and bacterins of Leptospira interrogans serovar Copenhageni (RP≥ 1.0). CONTENTS: 25 single dose vials of PROTECH C4 25 single dose vials of PROTECH C2I PROTECH® C4+2I Please note leaflet, label and tray only are recyclable. Protech® C4+2i is a registered trademark of Boehringer Ingelheim Vetmedica, Inc. BOEHRINGER INGELHEIM PTY LIMITED ANIMAL HEALTH DIVISION 78 WATERLOO ROAD NORTH RYDE NSW 2113 APVMA Approval No. 51489/56234 REVISION. . . . . . OPERATOR . . . . . DATE . . . . . . . . . ART #. . . . . . . . . ITEM # . . . . . . . PRODUCT . . . . . . TYPE/SIZE . . . . . . TEMPLATE #. . . . . DIMENSIONS . . . . CORNER RADIUS. . . PDF . . . . . . . . . . . REV LEVEL. . . . . . . BOEHRINGER INGELHEIM 7 lsh 22May12 176501-00 REQUESTED Protech C4+2i Tray / 25 x 1 mL 306 3” x 8-1/2” .312” 22May12 lsh 00 BLACK PMS 107 PMS 285 PMS 499 DIMENSIONS: 76.2 MM X 215.9 MM THIS FILE IS 100% WHEN PRINTED ON A4 (OR A3, AS APPLICABLE) FONT SIZES: MAIN PANEL: 6.5 pt TRADENAME: 13 pt SIDE PANEL: 6.5 pt Soma hati kamili